Adam D DeVore1, Margueritte Cox2, Zubin J Eapen2, Clyde W Yancy2, Deepak L Bhatt2, Paul A Heidenreich2, Eric D Peterson2, Gregg C Fonarow2, Adrian F Hernandez2. 1. From the Department of Medicine (A.D.D., Z.J.E., E.D.P., A.F.H.) and Duke Clinical Research Institute (A.D.D. M.C., Z.J.E., E.D.P., A.F.H.), Duke University School of Medicine, Durham, NC; Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, IL (C.W.Y.); Department of Medicine, Brigham and Women's Hospital, Heart and Vascular Center, Harvard Medical School, Boston, MA (D.L.B.); Department of Medicine, Veterans Affairs Palo Alto Health Care System, CA (P.A.H.); Stanford University, CA (P.A.H.); and Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles (G.C.F.). adam.devore@duke.edu. 2. From the Department of Medicine (A.D.D., Z.J.E., E.D.P., A.F.H.) and Duke Clinical Research Institute (A.D.D. M.C., Z.J.E., E.D.P., A.F.H.), Duke University School of Medicine, Durham, NC; Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, IL (C.W.Y.); Department of Medicine, Brigham and Women's Hospital, Heart and Vascular Center, Harvard Medical School, Boston, MA (D.L.B.); Department of Medicine, Veterans Affairs Palo Alto Health Care System, CA (P.A.H.); Stanford University, CA (P.A.H.); and Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles (G.C.F.).
Abstract
BACKGROUND: Previous data demonstrate early follow-up (ie, within 7 days of discharge) after a hospitalization for heart failure is associated with a lower risk of readmission, yet is uncommon and varies widely across hospitals. Limited data exist on whether the use of early follow-up after discharge has improved over time. METHODS AND RESULTS: We used data from Get With The Guidelines-Heart Failure (GWTG-HF) linked to Medicare claims to examine temporal trends in early follow-up and to assess for patient and hospital characteristics associated with early scheduled follow-up. In the overall GWTG-HF cohort, we studied 52,438 patients discharged from 239 hospitals from 2009 to 2012. Scheduled early follow-up at the time of hospital discharge rose from 51% to 65% over time (P<0.001). After multivariable adjustment, patients with older age (odds ratio, 1.04; 95% confidence interval, 1.01-1.07), certain comorbidities (anemia, diabetes mellitus, and chronic kidney disease), and the use of anticoagulation at discharge (odds ratio, 1.16; 95% confidence interval, 1.11-1.22) were associated with greater likelihood for early scheduled follow-up. Patients treated in hospitals located in the Midwest (odds ratio, 0.67; 95% confidence interval, 0.50-0.91) were less likely to have early scheduled follow-up. In a subset of patients with linked Medicare claims, we observed smaller improvements in actual early follow-up visits over time from 26% to 30% (P=0.005). CONCLUSIONS: From 2009 to 2012, there was improvement in early scheduled outpatient follow-up and, in the subset analyzed, improvement in actual early follow-up visits for hospitalized patients with heart failure. However, substantial opportunities remain for improving heart failure transitional care.
BACKGROUND: Previous data demonstrate early follow-up (ie, within 7 days of discharge) after a hospitalization for heart failure is associated with a lower risk of readmission, yet is uncommon and varies widely across hospitals. Limited data exist on whether the use of early follow-up after discharge has improved over time. METHODS AND RESULTS: We used data from Get With The Guidelines-Heart Failure (GWTG-HF) linked to Medicare claims to examine temporal trends in early follow-up and to assess for patient and hospital characteristics associated with early scheduled follow-up. In the overall GWTG-HF cohort, we studied 52,438 patients discharged from 239 hospitals from 2009 to 2012. Scheduled early follow-up at the time of hospital discharge rose from 51% to 65% over time (P<0.001). After multivariable adjustment, patients with older age (odds ratio, 1.04; 95% confidence interval, 1.01-1.07), certain comorbidities (anemia, diabetes mellitus, and chronic kidney disease), and the use of anticoagulation at discharge (odds ratio, 1.16; 95% confidence interval, 1.11-1.22) were associated with greater likelihood for early scheduled follow-up. Patients treated in hospitals located in the Midwest (odds ratio, 0.67; 95% confidence interval, 0.50-0.91) were less likely to have early scheduled follow-up. In a subset of patients with linked Medicare claims, we observed smaller improvements in actual early follow-up visits over time from 26% to 30% (P=0.005). CONCLUSIONS: From 2009 to 2012, there was improvement in early scheduled outpatient follow-up and, in the subset analyzed, improvement in actual early follow-up visits for hospitalized patients with heart failure. However, substantial opportunities remain for improving heart failure transitional care.
Authors: Marc D Samsky; Andrew P Ambrosy; Erik Youngson; Li Liang; Padma Kaul; Adrian F Hernandez; Eric D Peterson; Finlay A McAlister Journal: JAMA Cardiol Date: 2019-05-01 Impact factor: 14.676
Authors: Clare L Atzema; Peter C Austin; Bing Yu; Michael J Schull; Cynthia A Jackevicius; Noah M Ivers; Paula A Rochon; Douglas S Lee Journal: CMAJ Date: 2018-12-17 Impact factor: 8.262
Authors: R Kannan Mutharasan; Faraz S Ahmad; Itai Gurvich; Hannah Alphs Jackson; Jan A Van Mieghem; Clyde W Yancy Journal: Circ Cardiovasc Qual Outcomes Date: 2018-07
Authors: Peter S Pang; Gregory J Fermann; Benton R Hunter; Phillip D Levy; Kathleen A Lane; Xiaochun Li; Mette Cole; Sean P Collins Journal: Circ Heart Fail Date: 2019-07-10 Impact factor: 8.790
Authors: Kara E MacLeod; John M Chapel; Matthew McCurdy; Jasmin Minaya-Junca; Diane Wirth; Anekwe Onwuanyi; Rashon I Lane Journal: Health Serv Res Date: 2021-02-12 Impact factor: 3.734
Authors: Leslie L Chang; Haolin Xu; Adam D DeVore; Roland A Matsouaka; Clyde W Yancy; Gregg C Fonarow; Larry A Allen; Adrian F Hernandez Journal: J Am Heart Assoc Date: 2018-04-01 Impact factor: 5.501